In detail, it has been known that alterations of the mTOR pathway are implicated in the pathogenesis of renal tumors arising in patients affected by the inherited tuberous sclerosis syndrome such as renal angiomyolipoma and related lesions [9, 10] and TSC-RCC [11, 12]. This evidence concerns the gene MTOR and kidney neoplasm.